SMLR · As filed with the SEC
Semler Scientific balance sheet, by quarter
The statement as Semler Scientific presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Balance Sheets · USD
| USD | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets: | ||||
| Cash and cash equivalents | 10,176,000 | 13,482,000 | 9,737,000 | 8,819,000 |
| Restricted cash | 135,000 | 134,000 | 134,000 | 133,000 |
| Short-term notes receivable | — | — | — | 6,100,000 |
| Short-term deposits | 270,000 | 270,000 | 250,000 | — |
| Trade accounts receivable, net of allowance for credit losses of $90 and $199 respectively | 2,558,000 | 2,831,000 | 3,139,000 | 4,378,000 |
| Receivable for Bitcoin collateral | 35,928,000 | — | — | — |
| Inventory | 485,000 | 558,000 | 370,000 | 358,000 |
| Prepaid expenses and other current assets | 3,954,000 | 4,623,000 | 4,822,000 | 2,900,000 |
| Total current assets | 53,506,000 | 21,898,000 | 18,452,000 | 22,688,000 |
| Assets for lease, net | 1,339,000 | 1,431,000 | 1,469,000 | 1,423,000 |
| Property and equipment, net | 325,000 | 368,000 | 427,000 | 487,000 |
| Long-term investments | 512,000 | 512,000 | 512,000 | 512,000 |
| Long-term notes receivable | 1,150,000 | 1,500,000 | 1,500,000 | — |
| Intangible digital assets | 539,844,000 | 496,865,000 | 263,504,000 | 214,633,000 |
| Other non-current assets | 1,000 | 23,000 | 64,000 | 85,000 |
| Deferred tax assets | — | — | 7,517,000 | — |
| Total assets | 596,677,000 | 522,597,000 | 293,445,000 | 239,828,000 |
| Liabilities and Stockholders' Equity | ||||
| Current liabilities: | ||||
| Accounts payable | 200,000 | 156,000 | 590,000 | 140,000 |
| Accrued expenses | 6,365,000 | 6,013,000 | 4,397,000 | 5,173,000 |
| Accrued contingent liability | — | 29,750,000 | 29,750,000 | — |
| Deferred revenue | 411,000 | 638,000 | 711,000 | 774,000 |
| Short-term debt | 20,000,000 | — | — | — |
| Other short-term liabilities | 240,000 | 215,000 | 219,000 | 226,000 |
| Total current liabilities | 27,216,000 | 36,772,000 | 35,667,000 | 6,313,000 |
| Long-term liabilities: | ||||
| Deferred tax liability | 13,294,000 | 6,161,000 | — | 2,765,000 |
| Long-term notes payable, net | 96,418,000 | 96,255,000 | 96,095,000 | — |
| Total long-term liabilities | 109,712,000 | 102,416,000 | 96,095,000 | 2,765,000 |
| Stockholders' equity: | ||||
| Common stock, $0.001 par value; 50,000,000 shares authorized; 15,356,617 and 9,770,908 shares issued, and 15,142,195 and 9,556,486 shares outstanding (treasury shares of 214,422 and 214,422), respectively | 15,000 | 14,000 | 10,000 | 9,000 |
| Additional paid-in capital | 339,900,000 | 280,463,000 | 125,673,000 | 130,039,000 |
| Retained earnings | 119,834,000 | 102,932,000 | 36,000,000 | 100,702,000 |
| Total stockholders' equity | 459,749,000 | 383,409,000 | 161,683,000 | 230,750,000 |
| Total liabilities and stockholders' equity | 596,677,000 | 522,597,000 | 293,445,000 | 239,828,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.